Mel Hayes

2023

In 2023, Mel Hayes earned a total compensation of $2.2M as Executive Vice President, Patient Affairs at Fulcrum Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$160,300
Option Awards$1,561,354
Salary$471,200
Total$2,192,854

Hayes received $1.6M in option awards, accounting for 71% of the total pay in 2023.

Hayes also received $160.3K in non-equity incentive plan and $471.2K in salary.

Rankings

In 2023, Mel Hayes' compensation ranked 461st out of 2,790 executives tracked by ExecPay. In other words, Hayes earned more than 83.5% of executives.

ClassificationRankingPercentile
All
461
out of 2,790
84th
Division
Manufacturing
265
out of 1,530
83rd
Major group
Chemicals And Allied Products
184
out of 869
79th
Industry group
Drugs
181
out of 832
78th
Industry
Pharmaceutical Preparations
112
out of 597
81st
Source: SEC filing on April 19, 2024.

Hayes' colleagues

We found five more compensation records of executives who worked with Mel Hayes at Fulcrum Therapeutics in 2023.

2023

Alex Sapir

Fulcrum Therapeutics

Chief Executive Officer

2023

Curtis Oltmans

Fulcrum Therapeutics

Chief Legal Officer

2023

Alan Musso

Fulcrum Therapeutics

Chief Financial Officer

2023

Bryan Stuart

Fulcrum Therapeutics

Chief Executive Officer

2023

Robert Gould

Fulcrum Therapeutics

Chief Executive Officer

News

In-depth

You may also like